ArticlePharmaceuticals (Basel, Switzerland)2024

Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells.

Valerii E Orel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.